Treatment selection for gastric cancer with portal hypertension: clinical management

Author： Jin Zhou-Xiang   Ma Yong-Yong   Wang Xiang-Yu   Li Li-Jun   Zheng Zhi-Qiang  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.17, Iss.2, 2014-04, pp. : 302-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Docetaxel in the treatment of gastric cancer

By Thuss-Patience Peter C   Kretzschmar Albrecht   Reichardt Peter  

Future Oncology, Vol. 2, Iss. 5, 2006-10 ,pp. : 603-620

Future Medicine

Access to resources Recommend Favorite

Capecitabine in the treatment of advanced gastric cancer

By Lee Jae-Lyun   Kang Yoon-Koo  

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 179-198

Future Medicine

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: Efficacy of therapy and value of serum tumor markers

By Schulze-Bergkamen Henning   Zuna Ivan   Teufel Andreas   Stremmel Wolfgang   Rudi Jochen  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 43-53

Humana Press, Inc

Access to resources Recommend Favorite

Clinical significance of skip metastasis in patients with gastric cancer

By Saito Hiroaki   Tsujitani Shunichi   Ikeguchi Masahide  

Gastric Cancer, Vol. 10, Iss. 2, 2007-06 ,pp. : 87-91

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance and role of LKB1 in gastric cancer

By                      

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 249-256

Spandidos Publications

Access to resources Recommend Favorite